Safety/Efficacy Study of SGN-15 (Antibody-Drug Conjugate) Combined With Gemcitabine in Patients With Ovarian Cancer

This study has been terminated.

Study NCT00051584 Information provided by Seattle Genetics, Inc.

First Received: January 13, 2003 Last Updated: October 21, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	May 2003
Estimated Primary Completion Date:	No date given